509 related articles for article (PubMed ID: 34453639)
1. The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance.
Patil K; Khan FB; Akhtar S; Ahmad A; Uddin S
Cancer Metastasis Rev; 2021 Sep; 40(3):691-720. PubMed ID: 34453639
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer stem cells: emerging target for designing novel therapy.
Li Y; Kong D; Ahmad A; Bao B; Sarkar FH
Cancer Lett; 2013 Sep; 338(1):94-100. PubMed ID: 22445908
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer stem cells: A state or an entity?
Hermann PC; Sainz B
Semin Cancer Biol; 2018 Dec; 53():223-231. PubMed ID: 30130664
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer stem cells and EMT in drug resistance and metastasis.
Sarkar FH; Li Y; Wang Z; Kong D
Minerva Chir; 2009 Oct; 64(5):489-500. PubMed ID: 19859039
[TBL] [Abstract][Full Text] [Related]
5. Concise Review: Stem Cells in Pancreatic Cancer: From Concept to Translation.
Raj D; Aicher A; Heeschen C
Stem Cells; 2015 Oct; 33(10):2893-902. PubMed ID: 26202953
[TBL] [Abstract][Full Text] [Related]
6. Targeting pancreatic cancer stem cells for cancer therapy.
Xia J; Chen C; Chen Z; Miele L; Sarkar FH; Wang Z
Biochim Biophys Acta; 2012 Dec; 1826(2):385-99. PubMed ID: 22728049
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem cell in the progression and therapy of pancreatic cancer.
Xu L
Front Biosci (Landmark Ed); 2013 Jun; 18(3):795-802. PubMed ID: 23747847
[TBL] [Abstract][Full Text] [Related]
8. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.
Tanase CP; Neagu AI; Necula LG; Mambet C; Enciu AM; Calenic B; Cruceru ML; Albulescu R
World J Gastroenterol; 2014 Aug; 20(31):10790-801. PubMed ID: 25152582
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer stem cells: new insight into a stubborn disease.
Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
[TBL] [Abstract][Full Text] [Related]
11. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).
Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA
Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137
[TBL] [Abstract][Full Text] [Related]
12. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
[TBL] [Abstract][Full Text] [Related]
13. Understanding the molecular mechanisms that regulate pancreatic cancer stem cell formation, stemness and chemoresistance: A brief overview.
Nagaraju GP; Farran B; Luong T; El-Rayes BF
Semin Cancer Biol; 2023 Jan; 88():67-80. PubMed ID: 36535506
[TBL] [Abstract][Full Text] [Related]
14. Concomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side population of human pancreatic cancer cells.
Wang X; Liu Q; Hou B; Zhang W; Yan M; Jia H; Li H; Yan D; Zheng F; Ding W; Yi C; Hai Wang
PLoS One; 2013; 8(9):e73942. PubMed ID: 24040121
[TBL] [Abstract][Full Text] [Related]
15. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
[TBL] [Abstract][Full Text] [Related]
16. Garcinol downregulates Notch1 signaling via modulating miR-200c and suppresses oncogenic properties of PANC-1 cancer stem-like cells.
Huang CC; Lin CM; Huang YJ; Wei L; Ting LL; Kuo CC; Hsu C; Chiou JF; Wu ATH; Lee WH
Biotechnol Appl Biochem; 2017 Mar; 64(2):165-173. PubMed ID: 26400206
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
Wang C; Yin W; Liu H
J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer stemness: dynamic status in malignant progression.
Zhao Y; Qin C; Zhao B; Wang Y; Li Z; Li T; Yang X; Wang W
J Exp Clin Cancer Res; 2023 May; 42(1):122. PubMed ID: 37173787
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
20. Functions of the CXC ligand family in the pancreatic tumor microenvironment.
Lee NH; Nikfarjam M; He H
Pancreatology; 2018 Oct; 18(7):705-716. PubMed ID: 30078614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]